1 Australasian Section, American Oil Chemists’ Society December 2016, Newsletter From the President Hello, Another year has flown by. On behalf of the Australasian Section Committee, I would like to wish all members and colleagues a safe and happy Christmas and a prosperous new year. From the AAOCS, I would like you all to mark down Sept 11-13 in your diaries as the next and 10 th AAOCS conference. It will be in the beautiful Barossa Valley, SA in a Chateau (see pic). We are hoping to deliver a great/memorable experience along with high quality scientific and industry relevant presentations. The next theme is “Biotechnology, lipidomics and nutrition” and has some high quality keynote speakers to cover those topics (including Prof Kent Chapman, University of North Texas on biotechnology and Associate Professor Peter Meikle (Baker IDI) who leads the Metabolism Program and is Head of the Metabolomics Laboratory). So please save these dates, prepare an abstract/talk, invite your friends/colleagues, and join us for the 2017 AAOCS meeting. There might even be some wine tastings. https://aaocs2017.wordpress.com/ The AAOCS recently helped to organise and support the 2016 NZ fats and oils conference in Nelson NZ. This was a wonderful event with some very high quality presentations and some great discussions. We would like to thank Laurence Eyres who was the driving force for this conference. Please see article below for more information. Personally, I have had an amazing year. I have seen some amazing science (and people) in a trip to Japan, and my second child, Hazel Marie, arriving in August was probably the big highlight. Again we wish you a safe and happy Christmas. Matt Miller President, Australasian Section
14
Embed
Australasian Section, American Oil Chemists’ Society › Documents › Membership › Sections › ... · Australasian Section, American Oil Chemists’ Society . December 2016,
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Australasian Section, American Oil Chemists’ Society
December 2016, Newsletter
From the President Hello,
Another year has flown by. On behalf of the Australasian Section Committee, I
would like to wish all members and colleagues a safe and happy Christmas and a
prosperous new year.
From the AAOCS, I would like you all to mark down Sept 11-13 in your diaries as
the next and 10th AAOCS conference. It will be in the beautiful Barossa Valley, SA in
a Chateau (see pic). We are hoping to deliver a great/memorable experience along
with high quality scientific and industry relevant presentations. The next theme is
“Biotechnology, lipidomics and nutrition” and has some high quality keynote
speakers to cover those topics
(including Prof Kent Chapman,
University of North Texas on
biotechnology and Associate
Professor Peter Meikle (Baker IDI)
who leads the Metabolism Program
and is Head of the Metabolomics
Laboratory). So please save these
dates, prepare an abstract/talk, invite
your friends/colleagues, and join us for the 2017 AAOCS meeting. There might even
be some wine tastings. https://aaocs2017.wordpress.com/
The AAOCS recently helped to organise and support the 2016 NZ fats and oils
conference in Nelson NZ. This was a wonderful event with some very high quality
presentations and some great discussions. We would like to thank Laurence Eyres
who was the driving force for this conference. Please see article below for more
information.
Personally, I have had an amazing year. I have seen some amazing science (and
people) in a trip to Japan, and my second child, Hazel Marie, arriving in August was
� EPA and DHA act through multiple, increasingly understood, molecular and
cellular mechanisms to affect cell and tissue function
� Through these actions marine w3 fatty acids act to promote and maintain
health and to reduce disease risk
� Marine w3 fatty acids are important throughout the life course
� There is robust evidence that long-term intake of marine w3 fatty acids
reduces risk of coronary heart disease – due to beneficial impacts on a range
of risk factors
Australian and New Zealand Fish Oils – New Study Published in Nutrients Peter Nichols, CSIRO
Over the past 2 years several papers from the Liggins Institute/University of
Auckland and collaborators have been published questioning the quality of
Australian and New Zealand (ANZ) fish oil products. Considerable negative media
followed. The authors stated that products did not meet label omega 3 content
claims and were heavily oxidized. AAOCS readers have seen various updates from
the ANZ Omega-3 Centre (O3C) over this period. In November the results for
independent analyses commissioned by the O3C were published in Nutrients -
http://www.mdpi.com/2072-6643/8/11/703. The results were also presented at the
two conferences summarized above. The Nutrients paper clearly showed that ANZ
fish oils, when analysed by certified and Therapeutic Goods Administration
approved laboratories, are not oxidized and do meet their omega 3 label claims.
Australian and New Zealand Fish Oil Products in 2016 Meet Label Omega-3 Claims and Are Not Oxidized Abstract: We provide new fish oil product results to assist industry in Australia and New Zealand and, ultimately, consumers in understanding the high product quality assurance protocols in place, together with the high product quality that has been determined by both industry and independent laboratories. Fish oil capsule products common to Australia and New Zealand were purchased in May 2016 in Richmond, Victoria, Australia. Products were from two groups; five standard fish oil products and five fish oil concentrates. Noting Therapeutic Goods Administration (TGA) requirement for use of standard methods, for all analyses undertaken a laboratory was selected that met the TGA criteria, including with accreditation. Total n-3 content exceeded the label-claimed content for all 10 products, with supplements containing on average 124% of the claimed content (range 115%–136%); eicosapentaenoic acid and docosahexaenoic acid (EPA + DHA) content averaged 109% of the label claim (range 99%–119%). All 10 products (100%) similarly met the international recommended peroxide value (PV) level. Anisidine value (pAV) met the international recommended level for eight of the 10 products, with two products known to contain
flavourings that interfere with the pAV test. When accredited laboratories and standard protocols are used, Australian and New Zealand fish oil products have been shown to clearly meet their label claims for EPA + DHA content, and are not oxidized.
The Nutrients paper has been circulated to a range of societies and other outlets and
the AAOCS section committee has discussed and endorsed the statements of the
ANZ O3C.
UQ’s algae pilot is about to expand into commercial output Geoff Wilson, Director, Qponics Limited
The University of Queensland’s algae production pilot plant is about to become a
new model for low-cost but state-of-the-art commercial raceway algae farms around
the world.
Qponics Limited is an Australian start-up company which is preparing to
commercialise UQ-developed technology. It is planning to construct an algae farm
near Brisbane to produce human food ingredients – namely EPA omega-3 oil and
high-quality algal protein. First sales are expected during the 2017-18 financial year.
R&D from staff and students at UQ led by Professor Peer Schenk, has resulted
in more productive open and closed pond systems for growing and harvesting many
different species of algae. Qponics has chosen to begin with a Queensland strain of
Nannochloropsis – which is a local species of algae the university has optimised to
produce nearly 40% of omega-3 (EPA) in its fatty acids.
UQ has collected numerous species of algae over a number of years and several
of these have shown commercial value for production of nutraceutical and food
supplement products that are of interest to Qponics. Dr Graeme Barnett, CEO of
Qponics Limited said: “Over the last five years Qponics has reviewed algae
production technology from more than 60 overseas suppliers. Unfortunately, all were
found to be too expensive and not suited for algae farming in south-east
Queensland.
“Professor Schenk delighted us in February 2016 when he showed the Company
the latest productivity data from his research Algae Energy Farm at Pinjarra Hills in
Brisbane. UQ’s outdoor and covered raceway pond systems were subsequently
adopted by Qponics, and we were successful in winning a Cooperative Research
7
Centres Project (CRC-P) grant in June 2016 with the support of UQ to build our first
algae farm.”
While Qponics is initially focused on the production of omega-3 oil for the human
food supplement market, especially in Asia, the algae farm will also produce high-
2nd Australia New Zealand Marine Biotechnology Society joint with the 4th
International Conference on Coastal Biotechnology, August 7-11, 2017, Tauranga,
New Zealand
17th AOCS Latin American Congress and Exhibition on Fats, Oils, and Lipids
September 11–14, 2017, Grand Fiesta Americana Coral Beach Hotel,
Cancun, Mexico
2018 AOCS Annual Meeting & Expo, May 6–9, 2018, Minneapolis, Minnesota, USA
Fabric and Home Care World Conference, October 28–31, 2018, Boca Raton,
Florida, USA
Non AOCS events 8th European Symposium on Plant Lipids, July 2-5, 2017, Malmö, Sweden
57th International Conference on the Bioscience of Lipids, September 10-14, 2017,
Zurich, Switzerland
15th International Conference on Bioactive Lipids in Cancer Inflammation and
Related Diseases, October 22 - 25, 2017, Puerto Vallarta, Mexico
New Papers
Chang, K. L., Dunstan, G. A, Mansour, M. P., Jameson, I., Nichols, P. D. (2016) A
novel series of C18-C22 trans É3 PUFA from Northern and Southern hemisphere
strains of the marine Haptophyte Imantonia rotunda. Journal of Applied Phycology, in press.
Dias, C. B., Amigó, N., Wood, L. G., Mallol, R., Correig, X., Garg, M. L. (2017)
Dietary fat induced changes in low density lipoprotein characteristics are not
influenced by prior pre-supplementation with fish oil. Metabolism: Clinical and Experimental, 68: 11–19. http://dx.doi.org/10.1016/j.metabol.2016.11.014